Phase 1a initial single dose study of AV-101 in healthy volunters

Trial Profile

Phase 1a initial single dose study of AV-101 in healthy volunters

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs AV 101 (Primary)
  • Indications Neuropathic pain
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Jun 2017 Results from this trial published in a VistaGen Therapeutics Media Release.
    • 22 Jun 2017 According to a VistaGen Therapeutics media release, results from this study published in the Scandinavian Journal of Pain.
    • 21 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top